Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
253 hedge funds and large institutions have $3.94B invested in Arena Pharmaceuticals Inc in 2020 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 83 increasing their positions, 92 reducing their positions, and 30 closing their positions.
425% more call options, than puts
Call options by funds: $117M | Put options by funds: $22.3M
20% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 30
16% more capital invested
Capital invested by funds: $3.4B → $3.94B (+$541M)
2% more funds holding
Funds holding: 247 → 253 (+6)
10% less repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 92
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$143M |
| 2 |
Holocene Advisors
New York
|
+$45.9M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$38M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$21.9M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$59.8M |
| 2 |
BlackRock
New York
|
-$35.2M |
| 3 |
PA
Perceptive Advisors
New York
|
-$31.3M |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$25.8M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$24M |
ARNA Hedge Fund Activity: Q3 2020 in Review
253 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q3 2020, worth a combined $3.94B — up 16% from $3.4B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new ARNA positions and 30 closed out — a net gain of 6 holders — while 83 added to existing stakes and 92 trimmed.
The largest buyer was Avoro Capital Advisors, adding an estimated $143M. The largest seller was Citadel Advisors, cutting an estimated $59.8M.
- 253 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q3 2020, up from 247 in Q2 2020.
- Funds reported $3.94B of Arena Pharmaceuticals Inc stock for Q3 2020, up 16% quarter-over-quarter.
- 36 funds opened new Arena Pharmaceuticals Inc positions in Q3 2020 and 30 closed out, a net change of +6 holders.
- The largest Arena Pharmaceuticals Inc buyer in Q3 2020 was Avoro Capital Advisors, an estimated $143M added.
- The largest Arena Pharmaceuticals Inc seller in Q3 2020 was Citadel Advisors, an estimated $59.8M sold.
Based on aggregated 13F filings for Q3 2020.